Blog | Breast Imaging | September 14, 2022

The Use of Artificial Intelligence to Help Reduce False Positives

According to statistics from breastcancer.org, about 1 in 8 women in the US (around 13%) will develop invasive breast cancer over the course of her lifetime

According to statistics from breastcancer.org, about 1 in 8 women in the US (around 13%) will develop invasive breast cancer over the course of her lifetime. In 2022 alone, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the US, along with 51,400 new cases of non-invasive (in situ) breast cancer. About 43,250 of these women are expected to die from breast cancer. As for men, about 2,710 new cases of invasive breast cancer are expected to be diagnosed in 2022. A man’s lifetime risk of breast cancer is about 1 in 833.

The American Cancer Society reports that since 2007, breast cancer death rates have been steady in women younger than 50, but have continued to decrease in older women. From 2013 to 2018, the death rate went down by 1% per year, which is thought to be the result of earlier cancer screening detection and technological improvements. This number shows the power of early detection through screening, early diagnosis and treatment. It is no surprise that artificial intelligence (AI) is starting to be implemented into digital breast imaging technology and it shows promise in both interpretive and noninterpretive tasks.

Findings from a clinical trial that used artificial intelligence in an effort to reduce false positives on breast ultrasound were presented by Linda Moy, MD, Center for Advanced Imaging Innovation and Research with NYU Langone Health Center for Advanced Imaging Innovation and Research (CAI2R), during RSNA 2021. Researchers working on an initiative supported by the US National Science Foundation trained AI to identify breast cancer using data obtained from previously conducted ultrasounds. The AI tool significantly increased accurate diagnoses. The findings, and an analysis of this important study, can be found in the article “Artificial Intelligence System Reduces False-Positive Finding in the Interpretation of Breast Ultrasound Exams” on page 30 of this issue. The sidebar to this article also summarizes how, in a published study, AI decision support decreased unnecessary biopsies and follow-up exams because the system could be harnessed to support decision-making where there are shortages of radiologists.

Related Breast Imaging with AI Content:

Artificial Intelligence Tool Improves Accuracy of Breast Cancer Imaging

Southwest Diagnostic Imaging Center Uses Artificial Intelligence to Optimize Breast Tomosynthesis Interpretations

AI Provides Accurate Breast Density Classification


Related Content

News | RSNA

December 1, 2023 — The Society of Breast Imaging (SBI) announced that Elizabeth Morris, MD, has been selected as the SBI ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Hologic, Inc. showcased several recent developments in next-generation AI solutions at the 109th ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Breast cancer mortality is significantly reduced when women regularly attend screening mammograms ...

Time November 30, 2023
arrow
News | Breast Imaging

November 29, 2023 — A deep learning artificial intelligence (AI) model that was developed using only mammogram image ...

Time November 29, 2023
arrow
News | Artificial Intelligence

November 28, 2023 — iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and ...

Time November 28, 2023
arrow
News | RSNA

November 28, 2023 — iCAD, Inc., a global medical technology company developing cancer-detection solutions, will present ...

Time November 28, 2023
arrow
News | Breast Imaging

November 27, 2023 — Barco announces introduction of the DL Precise AI software in addition to the current Intuitive ...

Time November 27, 2023
arrow
Feature | RSNA

November 27, 2023 — The collective anticipation of the radiology community was palpable from early morning through ...

Time November 27, 2023
arrow
News | RSNA

November 22, 2023 — ScreenPoint Medical has announced that its Transpara breast AI has surpassed 5 million mammograms ...

Time November 22, 2023
arrow
News | FDA

November 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time November 22, 2023
arrow
Subscribe Now